Louis Moore Bacon's OGN Position Overview
Louis Moore Bacon (via Moore Capital Management, Lp) currently holds 177,385 shares of Organon & Co. (OGN) worth $1.27 M, representing 0.02% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Louis Moore Bacon has initiated a new position in OGN, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Louis Moore Bacon's Organon & Co (OGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Organon & Co (OGN) Trades by Louis Moore Bacon
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +177,385 | New Buy | 177,385 | $7.17 |
Louis Moore Bacon's Organon & Co Investment FAQs
Louis Moore Bacon first purchased Organon & Co. (OGN) in Q4 2025, acquiring 177,385 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon has held Organon & Co. (OGN) for 1 quarters since Q4 2025.
Louis Moore Bacon's largest addition to Organon & Co. (OGN) was in Q4 2025, adding 177,385 shares worth $1.27 M.
According to the latest 13F filing for Q4 2025, Louis Moore Bacon's firm, Moore Capital Management, Lp, owns 177,385 shares of Organon & Co. (OGN), valued at approximately $1.27 M.
As of the Q4 2025 filing, Organon & Co. (OGN) represents approximately 0.02% of Louis Moore Bacon's publicly disclosed stock portfolio, making it one of their key holdings.
Louis Moore Bacon's peak holding in Organon & Co. (OGN) was 177,385 shares, as reported at the end of Q4 2025.